百本醫護(02293.HK)遭債權人追債41萬元
百本醫護(02293.HK)公佈,公司及其間接全資附屬百本專業護理服務各自接獲一封函件,函件內附有一份債權人根據公司(清盤及雜項條文)條例發出之法定要求償債書,要求公司及百本專業護理服務支付債權人合共總額41.08萬元,即就債權人與公司所訂立聘用協議以及債權人向百本專業護理服務提供專業法律服務而言,未償還應付債權人法律服務費用。
償債書並載,若公司未能於三個星期內償付該款項或就該款項提供令債權人滿意之擔保或付款安排,則債券人可呈交清盤呈請,向法庭尋求頒令分別將公司及百本專業護理服務清盤。公司現正就有關事宜徵詢法律意見。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.